XML 64 R42.htm IDEA: XBRL DOCUMENT v3.10.0.1
SHARE-BASED COMPENSATION PLANS AND AWARDS (Tables)
12 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Assumptions Used in the Determination of Fair Value of Stock Options Awarded
The weighted average assumptions used in the determination of fair value for stock options awarded in 2018, 2017, and 2016 are provided in the table below:
Assumptions
 
2018
 
2017
 
2016
Expected volatility rate
 
19.03%
 
20.45%
 
23.71%
Expected dividend yield
 
2.48%
 
2.64%
 
2.31%
Average risk-free interest rate
 
2.61%
 
1.91%
 
1.23%
Expected term years
 
5.1
 
5.0
 
5.0

Schedule of Activity of Stock Option Awards
A summary of the activity of the Company's stock option awards for 2018, 2017, and 2016 is presented below:
 
2018
 
2017
 
2016
 
Options
 
Weighted-Average Exercise Price
 
Options
 
Weighted-Average Exercise Price
 
Options
 
Weighted-Average Exercise Price
Outstanding at beginning of year
2,614,100

 
$
70

 
2,363,700

 
$
61

 
2,434,600

 
$
53

Granted
619,700

 
104

 
745,800

 
80

 
554,000

 
65

Exercised
(323,000
)
 
55

 
(489,300
)
 
44

 
(618,500
)
 
33

Cancelled, forfeited, or expired
(5,200
)
 
78

 
(6,100
)
 
74

 
(6,400
)
 
77

Outstanding at end of year
2,905,600

 
$
79

 
2,614,100

 
$
70

 
2,363,700

 
$
61

Options exercisable at year-end
1,606,800

 
 
 
1,335,500

 
 
 
1,378,000

 
 
Available for grant at end of year
8,174,614

 
 
 
9,943,033

 
 
 
3,807,724

 
 

Schedule of Remaining Contractual Term and Weighted Average Exercise Price of Stock Options Outstanding and Exercisable
The following table provides the remaining contractual term and weighted average exercise prices of stock options outstanding and exercisable at December 31, 2018:
 
 
Options Outstanding
 
Options Exercisable
Range of Exercise Prices
 
Number Outstanding at
December 31, 2018
 
Weighted-Average Remaining Contractual Life (Years)
 
Weighted-Average Exercise Price
 
Number Exercisable at
December 31, 2018
 
Weighted-Average Exercise Price
$38-$50
 
182,500
 
2.5
 
$
39

 
182,500
 
$
39

$51-$73
 
742,300
 
6.2
 
67

 
557,500
 
67

$74-$89
 
1,361,100
 
7.1
 
80

 
866,800
 
79

$90-$104
 
619,700
 
9.2
 
104

 
0


 
 
2,905,600
 
7.0
 
$
79

 
1,606,800
 
$
70


Schedule of Summary of Status of Nonvested Options
A summary of the changes in the Company's nonvested options during the year ended December 31, 2018 is presented below:
Nonvested Options
 
Number of Options
 
Weighted-Average Grant Date Fair Value
Nonvested at January 1, 2018
 
1,278,600

 
$11.82
Granted
 
619,700

 
$15.90
Vested
 
(594,300
)
 
$12.10
Forfeited or expired
 
(5,200
)
 
$12.74
Nonvested options at December 31, 2018
 
1,298,800

 
$13.63